Your browser is no longer supported. Please, upgrade your browser.
AXGN AxoGen, Inc. monthly Stock Chart
AXGN [NASD]
AxoGen, Inc.
Index- P/E- EPS (ttm)-0.41 Insider Own14.00% Shs Outstand33.01M Perf Week-0.94%
Market Cap873.11M Forward P/E- EPS next Y-0.19 Insider Trans-34.19% Shs Float32.12M Perf Month6.22%
Income-13.60M PEG- EPS next Q-0.08 Inst Own67.90% Short Float3.04% Perf Quarter44.14%
Sales54.90M P/S15.90 EPS this Y8.40% Inst Trans1.30% Short Ratio3.38 Perf Half Y79.93%
Book/sh0.32 P/B82.66 EPS next Y40.60% ROA-31.10% Target Price27.17 Perf Year220.61%
Cash/sh0.67 P/C39.69 EPS next 5Y- ROE-111.00% 52W Range8.15 - 27.60 Perf YTD193.89%
Dividend- P/FCF- EPS past 5Y29.90% ROI- 52W High-4.17% Beta0.43
Dividend %- Quick Ratio2.90 Sales past 5Y53.30% Gross Margin84.50% 52W Low224.54% ATR1.11
Employees146 Current Ratio3.50 Sales Q/Q42.90% Oper. Margin-16.30% RSI (14)64.60 Volatility3.19% 3.86%
OptionableYes Debt/Eq2.30 EPS Q/Q16.50% Profit Margin-24.70% Rel Volume0.81 Prev Close26.20
ShortableYes LT Debt/Eq1.92 EarningsNov 01 AMC Payout- Avg Volume288.38K Price26.45
Recom1.50 SMA203.69% SMA5017.94% SMA20062.13% Volume233,830 Change0.95%
Nov-30-17Initiated Jefferies Buy $35
Nov-21-17Reiterated Lake Street Buy $22 → $26
Jul-31-17Initiated Leerink Partners Outperform $22
Jun-30-17Initiated Cantor Fitzgerald Overweight $18
Mar-06-17Initiated ROTH Capital Buy $14.50
Nov-22-16Upgrade Lake Street Hold → Buy $9 → $11
Nov-07-16Reiterated Wedbush Outperform $10 → $12
Nov-03-16Downgrade Lake Street Buy → Hold $9
Aug-04-16Reiterated Wedbush Outperform $9 → $10
May-14-14Initiated Dawson James Buy $5
Oct-31-13Reiterated Ladenburg Thalmann Buy $4.50 → $5.75
Dec-01-17 10:26AM  ETFs with exposure to AxoGen, Inc. : December 1, 2017 Capital Cube
Nov-30-17 07:25PM  Edited Transcript of AXGN earnings conference call or presentation 1-Nov-17 8:30pm GMT Thomson Reuters StreetEvents
Nov-20-17 11:15AM  AxoGen Announces Closing of Public Offering of Common Stock GlobeNewswire
10:00AM  AxoGen, Inc. (Nasdaq: AXGN) to Ring The Nasdaq Stock Market Opening Bell GlobeNewswire
08:00AM  AxoGen Advances its Platform for Nerve Repair at Annual Analyst and Investor Day GlobeNewswire
Nov-16-17 11:12AM  ETFs with exposure to AxoGen, Inc. : November 16, 2017 Capital Cube -9.24%
11:02AM  November Growth Stocks To Look Out For Simply Wall St.
08:40AM  AxoGen, Inc. Announces Pricing of Public Offering of Common Stock GlobeNewswire
Nov-15-17 04:43PM  AxoGen, Inc. Announces Proposed Public Offering of Common Stock GlobeNewswire
Nov-14-17 07:00AM  AxoGen, Inc. to Present at the 29th Annual Piper Jaffray Healthcare Conference GlobeNewswire
Nov-07-17 07:00AM  AxoGen to Host Second Annual Analyst and Investor Day on November 20, 2017 GlobeNewswire
Nov-06-17 11:08AM  ETFs with exposure to AxoGen, Inc. : November 6, 2017 Capital Cube
Nov-03-17 10:03AM  AxoGen, Inc. :AXGN-US: Earnings Analysis: Q3, 2017 By the Numbers : November 3, 2017 Capital Cube +7.91%
Nov-01-17 06:45PM  AxoGen reports 3Q loss Associated Press
04:05PM  AxoGen, Inc. Reports 2017 Third Quarter Financial Results GlobeNewswire
Oct-31-17 12:35PM  Is AxoGen Inc (AXGN) A Financially Sound Company? Simply Wall St.
Oct-25-17 09:51AM  ETFs with exposure to AxoGen, Inc. : October 25, 2017 Capital Cube
Oct-18-17 07:00AM  AxoGen, Inc. Receives David J. Gury Company of the Year Award from BioFlorida GlobeNewswire
Oct-17-17 07:00AM  AxoGen, Inc. to Report Third Quarter 2017 Financial Results and Host Conference Call on November 1, 2017 GlobeNewswire
Oct-13-17 10:31AM  ETFs with exposure to AxoGen, Inc. : October 13, 2017 Capital Cube
Oct-02-17 10:41AM  ETFs with exposure to AxoGen, Inc. : October 2, 2017 Capital Cube
07:00AM  AxoGen to Participate at 99th Annual American Association of Oral and Maxillofacial Surgeons Meeting GlobeNewswire
Sep-22-17 10:16AM  ETFs with exposure to AxoGen, Inc. : September 22, 2017 Capital Cube
Sep-11-17 09:19PM  ETFs with exposure to AxoGen, Inc. : September 12, 2017 Capital Cube
07:00AM  AxoGen, Inc. to Present at the Cantor Fitzgerald Global Healthcare Conference GlobeNewswire
Sep-08-17 05:23PM  AxoGen, Inc. :AXGN-US: Earnings Analysis: Q2, 2017 By the Numbers : September 8, 2017 Capital Cube
Aug-25-17 04:10PM  Edited Transcript of AXGN earnings conference call or presentation 2-Aug-17 8:30pm GMT Thomson Reuters StreetEvents
Aug-24-17 07:00AM  AxoGen to Participate at 72nd Annual American Society for Surgery of the Hand Meeting GlobeNewswire
Aug-15-17 09:08AM  AxoGen, Inc. breached its 50 day moving average in a Bullish Manner : AXGN-US : August 15, 2017 Capital Cube
Aug-11-17 07:36PM  AxoGen, Inc. Value Analysis (NASDAQ:AXGN) : August 11, 2017 Capital Cube
Aug-02-17 10:46PM  AxoGen reports 2Q loss Associated Press
04:01PM  AxoGen, Inc. Reports 2017 Second Quarter Financial Results GlobeNewswire
10:50AM  Investor Network: AxoGen, Inc. to Host Earnings Call ACCESSWIRE
Jul-31-17 07:00AM  AxoGen, Inc. to Present at the Wedbush PacGrow Healthcare Conference GlobeNewswire
Jul-28-17 09:32AM  AxoGen, Inc. breached its 50 day moving average in a Bearish Manner : AXGN-US : July 28, 2017 Capital Cube
Jul-20-17 05:00PM  AxoGen, Inc. Discloses Terms of Recent Equity Award GlobeNewswire
Jul-19-17 07:00AM  AxoGen, Inc. to Report Second Quarter 2017 Financial Results and Host Conference Call on Wednesday, August 2, 2017 GlobeNewswire
Jul-17-17 07:00AM  AxoGen, Inc. Appoints Jon Gingrich Chief Commercial Officer GlobeNewswire
Jun-08-17 01:24PM  ETFs with exposure to AxoGen, Inc. : June 8, 2017 Capital Cube
Jun-07-17 07:00AM  AxoGen, Inc. to Present at the JMP Securities Life Sciences Conference GlobeNewswire
May-23-17 07:00AM  AxoGen, Inc. to Present at the Jefferies Global Healthcare Conference GlobeNewswire
May-22-17 08:20AM  AxoGen (AXGN) Shows Strength: Stock Adds 6.1% in Session Zacks
May-15-17 03:19PM  ETFs with exposure to AxoGen, Inc. : May 15, 2017 Capital Cube
May-10-17 11:18AM  AxoGen, Inc. :AXGN-US: Earnings Analysis: Q1, 2017 By the Numbers : May 10, 2017 Capital Cube
May-04-17 07:09PM  AxoGen reports 1Q loss Associated Press
04:02PM  AxoGen, Inc. Reports 2017 First Quarter Financial Results GlobeNewswire
10:00AM  Investor Network: AxoGen, Inc. to Host Earnings Call Accesswire
May-02-17 03:43PM  ETFs with exposure to AxoGen, Inc. : May 2, 2017 Capital Cube
Apr-17-17 12:47PM  ETFs with exposure to AxoGen, Inc. : April 17, 2017 Capital Cube
Apr-14-17 07:00AM  AxoGen, Inc. to Report First Quarter 2017 Financial Results and Host Conference Call on Thursday, May 4, 2017 GlobeNewswire
Apr-11-17 07:12PM  Cramer Remix: Why a slew of IPOs might not be a good thin... CNBC Videos
Apr-07-17 08:30AM  AxoGen, Inc. Announces 2017 Annual Shareholders Meeting GlobeNewswire
Apr-05-17 04:22PM  ETFs with exposure to AxoGen, Inc. : April 5, 2017 Capital Cube
Apr-03-17 08:17AM  AxoGen, Inc. breached its 50 day moving average in a Bullish Manner : AXGN-US : April 3, 2017 Capital Cube
Mar-17-17 12:08PM  AxoGen, Inc. :AXGN-US: Earnings Analysis: Q4, 2016 By the Numbers : March 17, 2017 Capital Cube
Mar-10-17 01:43PM  AxoGen, Inc. :AXGN-US: Earnings Analysis: 2016 By the Numbers : March 10, 2017 Capital Cube
Mar-07-17 01:04PM  AXOGEN, INC. Financials
07:00AM  AxoGen, Inc. to Present at the Oppenheimer 27th Annual Healthcare Conference GlobeNewswire
Mar-06-17 09:27AM  AxoGen, Inc. breached its 50 day moving average in a Bearish Manner : AXGN-US : March 6, 2017 Capital Cube
08:23AM  Coverage initiated on AxoGen by ROTH Capital
Mar-02-17 08:00AM  AxoGen, Inc. to Present at Upcoming Investor Conferences GlobeNewswire
Mar-01-17 04:15PM  AXOGEN, INC. Files SEC form 10-K, Annual Report
Feb-22-17 04:44PM  AXOGEN, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:16PM  AxoGen reports 4Q loss Associated Press
04:01PM  AxoGen, Inc. Reports 2016 Fourth Quarter and Full Year Financial Results GlobeNewswire
Feb-08-17 07:00AM  AxoGen, Inc. to Report Fourth Quarter and 2016 Full Year Financial Results and Host Conference Call on Wednesday, February 22, 2017 GlobeNewswire
Jan-26-17 04:58PM  AXOGEN, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Jan-18-17 09:30AM  Zacks.com featured highlights: AxoGen, MAG Silver, Triumph Bancorp, UCP and Yelp
Jan-09-17 07:31AM  AXOGEN, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits +10.75%
07:00AM  AxoGen, Inc. Preannounces Estimated Fourth Quarter and Full Year 2016 Revenue GlobeNewswire
Jan-05-17 04:01PM  AxoGen Appoints Ivica Ducic Medical Director GlobeNewswire
Jan-03-17 05:06PM  AXOGEN, INC. Files SEC form 8-K, Change in Directors or Principal Officers
07:00AM  AxoGen to Participate at AAHS ASPN ASRM Joint 2017 Annual Meeting GlobeNewswire
Dec-30-16 10:53AM  ETFs with exposure to AxoGen, Inc. : December 30, 2016
Dec-14-16 12:44PM  ETFs with exposure to AxoGen, Inc. : December 14, 2016
07:00AM  AxoGen, Inc. announces Avance® Nerve Graft Recipient to be honored on the Donate Life Tournament of Roses Parade Float GlobeNewswire
Dec-10-16 11:03AM  Hedge Funds Are Betting On AxoGen, Inc. (AXGN) at Insider Monkey
Nov-21-16 07:00AM  AxoGen, Inc. Announces Commercial Release and First Clinical Implant of Avive Soft Tissue Membrane GlobeNewswire
Nov-17-16 07:00AM  AxoGen, Inc. to Present at the 28th Annual Piper Jaffray Healthcare Conference GlobeNewswire
Nov-15-16 07:00AM  AxoGen, Inc. to Host Analyst and Investor Event on November 21, 2016 GlobeNewswire
Nov-07-16 12:07PM  ETFs with exposure to AxoGen, Inc. : November 7, 2016
Nov-04-16 11:31AM  AxoGen, Inc. :AXGN-US: Earnings Analysis: Q3, 2016 By the Numbers : November 4, 2016 -6.40%
Nov-02-16 06:19PM  AxoGen reports 3Q loss
04:17PM  AXOGEN, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:08PM  AXOGEN, INC. Files SEC form 10-Q, Quarterly Report
04:01PM  AxoGen, Inc. Reports Financial Results for Third Quarter 2016 GlobeNewswire
07:07AM  Q3 2016 AxoGen Inc Earnings Release - After Market Close
Oct-31-16 04:17PM  AXOGEN, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Definitive Agr
Oct-26-16 07:00AM  AxoGen, Inc. Announces the Refinancing of its Debt Facility GlobeNewswire
Oct-19-16 07:00AM  AxoGen, Inc. to Report Third Quarter Financial Results and Host Conference Call on Wednesday, November 2, 2016 GlobeNewswire
Oct-13-16 04:33PM  AXOGEN, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements and E
04:05PM  AxoGen Announces Closing of Public Offering of Common Stock and Underwriters Full Exercise of Option to Purchase Additional Shares GlobeNewswire
Oct-12-16 09:39AM  ETFs with exposure to AxoGen, Inc. : October 12, 2016
Oct-07-16 09:00AM  AxoGen Announces Pricing of Public Offering of Common Stock GlobeNewswire +11.04%
Oct-06-16 04:05PM  AxoGen Announces Proposed Public Offering of Common Stock GlobeNewswire
Sep-27-16 09:52AM  ETFs with exposure to AxoGen, Inc. : September 27, 2016
Sep-26-16 08:41AM  Allergan Gets FDA Approval for New Line of Breast Implants
Sep-19-16 09:02AM  AXOGEN, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
07:00AM  AxoGen, Inc. Appoints Amy Wendell to Board of Directors GlobeNewswire
Sep-15-16 07:00AM  AxoGen to Participate at 71st Annual American Society for Surgery of the Hand Meeting GlobeNewswire
AxoGen, Inc. provides surgical solutions for peripheral nerve injuries. The company's surgical nerve repair solutions include Avance Nerve Graft, an off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect injured peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments. Its solutions also comprise Avive Soft Tissue Membrane, a minimally processed human umbilical cord membrane that is used as a resorbable soft tissue covering to separate tissues and modulate inflammation in the surgical bed. In addition, the company offers AcroVal neurosensory and motor testing system, which consists of AcroGrip for use in hand grip strength measurement; AcroPinch for measuring pinch strength; and Pressure-Specified Sensory Device, a somatosensory evaluation and measurement device. Further, it provides AxoTouch two point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. The company provides its products to hospitals, surgery centers, and military hospitals in the United States, Canada, the United Kingdom and other European countries, and internationally. AxoGen, Inc. is headquartered in Alachua, Florida.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Grooms Jamie MarkDirectorDec 08Sale26.3731,805838,698281,312Dec 08 06:30 PM
Grooms Jamie MarkDirectorDec 07Sale26.5031,200826,800313,117Dec 08 06:30 PM
Grooms Jamie MarkDirectorDec 06Sale26.2221,290558,224344,317Dec 08 06:30 PM
NEELS GUIDO JDirectorNov 20Sale19.741,150,00022,701,0003,371,111Nov 21 03:31 PM
Essex Woodlands Fund IX, L.P.10% OwnerNov 20Sale19.741,150,00022,701,0003,711,111Nov 21 03:31 PM
Gold Mark StephenDirectorNov 13Option Exercise5.0915,00076,350360,248Nov 15 11:22 AM
Grooms Jamie MarkDirectorNov 01Option Exercise0.2714,3793,882365,796Nov 03 04:56 PM
Friedman Mark LouisVP,Regulatory & QualityOct 24Option Exercise2.5867,767174,96267,952Oct 26 05:04 PM
Freitag Gregory GeneGeneral Counsel & SVP BDSep 25Option Exercise2.7410,00027,400101,116Sep 27 05:22 PM
Rudelius Robert JamesDirectorSep 11Sale18.0016,143290,57423,273Sep 12 04:02 PM
Rudelius Robert JamesDirectorSep 08Option Exercise3.5020,00070,00043,273Sep 12 04:02 PM
Freitag Gregory GeneGeneral Counsel & SVP BDAug 27Option Exercise2.7423,00063,02094,901Aug 29 04:58 PM
Gold Mark StephenDirectorMay 30Option Exercise8.955,00044,750345,248Jun 01 01:51 PM
Gold Mark StephenDirectorMay 22Option Exercise4.8115,00072,150340,248May 26 04:24 PM
Donovan Michael PatrickVP OperationsMar 14Option Exercise1.559,65914,9589,659Mar 14 07:32 PM
DeVinney Erick WayneVP, Clinical&Translational ScMar 14Option Exercise0.275,0181,3555,018Mar 14 07:32 PM
Freitag Gregory GeneGeneral Counsel & SVP BDDec 30Option Exercise2.7423,00063,02071,901Mar 14 07:31 PM